Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.

Diabetic medicine : a journal of the British Diabetic Association - 1 Sept 1997

Vauhkonen I, Niskanen L, Ryynänen M, Voutilainen R, Partanen J, Töyry J, Mercuri M, Rauramaa R, Uusitupa M

Abstract excerpt

We analysed a well-characterized group of 83 patients (43 men, 40 women; mean age +/- SEM: 65.5 +/- 0.6 years at the 10-year examination) with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) and in 123 control subjects (56 men, 67 women; mean age +/- 0.9 years) retrospectively for the relationship of apolipoprotein E (apo E) genotypes (E2/3, E3/3 vs E3/4, E4/4) to the incidence of clinical macrovascular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Diabetes Mellitus, Type 2

Share to Follow-Up Studies

Share to Gene Frequency

Share to Genotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 9300224
DOI: 10.1002/(SICI)1096-9136(199709)14:9<748::AID-DIA469>3.0.CO;2-N

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.PMID 9300224Read ↗

Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.Semantic proximity Read ↗

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.Semantic proximity Read ↗

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?Semantic proximity Read ↗

Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients.Semantic proximity Read ↗

Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.Semantic proximity Read ↗

Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.Semantic proximity Read ↗

Macrovascular complication phenotypes in type 2 diabetic patients.Semantic proximity Read ↗

ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?Semantic proximity Read ↗

Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.Semantic proximity Read ↗

Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.